A class action lawsuit has been filed against Portillo's Inc. for allegedly making false and misleading statements about its rapid expansion and sales performance between September 2023 and May 2026. The complaint claims the company overexpanded in areas without strong brand recognition, cannibalized existing restaurants, and used promotions that hurt same-restaurant sales. Investors who bought Portillo's securities during this period may recover losses by joining the lawsuit before the January 11, 2027 deadline. The law firm Bronstein, Gewirtz & Grossman is representing affected investors on a contingency fee basis.
The class action lawsuit against Portillo's Inc. provides context for consumer cyclical stocks on Pluang. Of 134 priced US stocks in this sector, 32 rose and 101 fell today. Notable movers include Gogoro Inc (GGR) at USD 2.85 with a +5.56% change, Quantumscape Corp (QS) at USD 3.99 with a -5.23% change and 89% sell order activity, and NIO Inc. (NIO) at USD 3.08 with a -5.09% change and 98% sell order activity. This data is as of Nov 12, 2026 23:31 WIB.
D.A. Davidson raised Riskified's price target to $12, reflecting a 22.2% potential upside from $9.82. The company reported a 41% revenue increase to $115.2 million and adjusted earnings of $0.07 per share, beating estimates. Profitability improved wi...
TRM Labs introduced the Disruption Awards to recognize coalitions of public and private organizations that successfully disrupted major cybercrimes in 2026. Winners include groups that took down a phishing service responsible for most Microsoft-block...
Existing-home sales in the U.S. dropped 5.5% month-over-month and 8.8% year-over-year in October, reaching the lowest level since August 2010. The decline is attributed to mortgage rates rising to their highest since 2000, making home buying more dif...
The global specialty zeolites market, valued at $1 million in 2025, is projected to reach $1.5 million by 2032 with a 5.8% CAGR. Growth is fueled by stricter environmental regulations and rising demand in water treatment, petrochemicals, agriculture,...
The global cell lysis and cell fractionation market, valued at $2.8 billion in 2025, is projected to grow to $4.5 billion by 2032 at a 7% CAGR. Growth is fueled by advances in biotechnology, increased life sciences research investments, and rising de...
